✦ LIBER ✦

The clinical pharmacology of the adenosine deaminase inhibitor 2′-deoxycoformycin

✍ Scribed by John F. Smyth; Rosanne M. Paine; Ann L. Jackman; Kenneth R. Harrap; Marvin M. Chassin; Richard H. Adamson; David G. Johns

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of 2′-deoxycoformycin,

✍ J.D. Geiger; J.L. Lewis; C.J. MacIntyre; J.I. Nagy 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 524 KB

Metabolic abnormalities of human adenosi

✍ Howard Ratech; G.Jeanette Thorbecke; Rochelle Hirschhorn 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 552 KB

Activated T lymphocytes resist the toxic

✍ Malak Kotb; Bruce C. Veit 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 932 KB

REMISSION INDUCTION WITH ADENOSINE-DEAMI

✍ Prentice, H.Grant; Ganeshaguru, K.; Bradstock, KennethF.; Goldstone, AnthonyH.; 📂 Article 📅 1980 🏛 The Lancet 🌐 English ⚖ 418 KB

Selective immunotoxic effects in mice tr

✍ Robert W. Luebke; Lela D. Lawson; Ronald R. Rogers; Marie M. Riddle; Denise G. R 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 714 KB

Enhancement of the biological activity o

✍ David G. Johns; Richard H. Adamson 📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 276 KB